Balyasny Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $111M | Sell |
|
|||||
|
2025
Q2 | $106M | Buy |
|
|||||
|
2025
Q1 | $63.9M | Buy |
|
|||||
|
2024
Q4 | $1.74M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $3.6M | Buy |
|
|||||
|
2024
Q1 | $1.19M | Buy |
|
|||||
|
2023
Q4 | $512K | Buy |
|
|||||
|
2023
Q3 | $399K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $11.3M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $28.6M | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $334K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $20.2M | Sell |
|
|||||
|
2018
Q3 | $39M | Buy |
|
|||||
|
2018
Q2 | $26.6M | Buy |
|
|||||
|
2018
Q1 | $27.1M | Buy |
|
|||||
|
2017
Q4 | $7.28M | Sell |
|
|||||
|
2017
Q3 | $20M | Sell |
|
|||||
|
2017
Q2 | $27.3M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $36.3M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $12M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4.92M | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $4.28M | Buy |
|